Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195870 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2025-08-29 | 2025-09-18 | 266190 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-10-19 | 2024-02-22 | 207536 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2020-03-26 | 2020-09-10 | 109607 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-03-14 | 2018-09-13 | 2256 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155180 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-03-14 | 2018-09-13 | 2218 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2019-08-15 | 2019-10-04 | 91645 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2021-11-25 | 2021-12-02 | 149942 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Actual shortage | 2026-01-15 | 2026-01-15 | 276236 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2022-09-22 | 2023-04-28 | 169973 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2020-05-21 | 2020-08-13 | 115547 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2017-08-01 | 2018-07-03 | 17899 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2025-05-30 | 2025-08-29 | 259020 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2024-12-13 | 2025-01-23 | 245609 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176836 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2025-03-20 | 2025-05-08 | 253153 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2019-08-29 | 2019-11-21 | 92675 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176839 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110749 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258691 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2025-05-27 | 2025-05-27 | 258359 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2021-02-12 | 2021-02-12 | 133886 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| COUGH SYRUP WITH CODEINE | 30MG 3.3MG 100MG | SYRUP SYRUP | Reversed | 2025-05-28 | 2025-06-03 | 258600 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 |